Annual Total Liabilities
$8.49 M
+$5.01 M+143.93%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual total liabilities is $8.49 million, with the most recent change of +$5.01 million (+143.93%) on December 31, 2023.
- During the last 3 years, CYTH annual total liabilities has risen by +$4.75 million (+127.29%).
- CYTH annual total liabilities is now at all-time high.
Performance
CYTH Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$18.73 M
+$8.89 M+90.30%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly total liabilities is $18.73 million, with the most recent change of +$8.89 million (+90.30%) on September 30, 2024.
- Over the past year, CYTH quarterly total liabilities has increased by +$10.24 million (+120.57%).
- CYTH quarterly total liabilities is now at all-time high.
Performance
CYTH Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CYTH Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +143.9% | +120.6% |
| 3 y3 years | +127.3% | +120.6% |
| 5 y5 years | +341.0% | +120.6% |
CYTH Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +143.9% | at high | +791.0% |
| 5 y | 5-year | at high | +167.2% | at high | +791.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Cyclo Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $18.73 M(+90.3%) |
| Jun 2024 | - | $9.84 M(+50.2%) |
| Mar 2024 | - | $6.55 M(-22.8%) |
| Dec 2023 | $8.49 M(+143.9%) | $8.49 M(+27.7%) |
| Sep 2023 | - | $6.65 M(+8.5%) |
| Jun 2023 | - | $6.13 M(+35.1%) |
| Mar 2023 | - | $4.54 M(+30.3%) |
| Dec 2022 | $3.48 M(-9.6%) | $3.48 M(+21.1%) |
| Sep 2022 | - | $2.88 M(+36.8%) |
| Jun 2022 | - | $2.10 M(-26.9%) |
| Mar 2022 | - | $2.88 M(-25.3%) |
| Dec 2021 | $3.85 M(+3.0%) | $3.85 M(+10.9%) |
| Sep 2021 | - | $3.47 M(+11.3%) |
| Jun 2021 | - | $3.12 M(-18.4%) |
| Mar 2021 | - | $3.82 M(+2.3%) |
| Dec 2020 | $3.74 M(+17.6%) | $3.74 M(-19.8%) |
| Sep 2020 | - | $4.66 M(+11.4%) |
| Jun 2020 | - | $4.18 M(+5.0%) |
| Mar 2020 | - | $3.98 M(+25.4%) |
| Dec 2019 | $3.18 M(+65.0%) | $3.18 M(+33.6%) |
| Sep 2019 | - | $2.38 M(-13.5%) |
| Jun 2019 | - | $2.75 M(+2.4%) |
| Mar 2019 | - | $2.69 M(+39.5%) |
| Dec 2018 | $1.93 M(+104.2%) | $1.93 M(+16.3%) |
| Sep 2018 | - | $1.65 M(+28.4%) |
| Jun 2018 | - | $1.29 M(+20.7%) |
| Mar 2018 | - | $1.07 M(+13.3%) |
| Dec 2017 | $943.00 K(+175.3%) | $943.00 K(-16.6%) |
| Sep 2017 | - | $1.13 M(+99.5%) |
| Jun 2017 | - | $566.40 K(+156.3%) |
| Mar 2017 | - | $221.00 K(-35.5%) |
| Dec 2016 | $342.50 K(-65.6%) | $342.50 K(-60.9%) |
| Sep 2016 | - | $875.90 K(-22.0%) |
| Jun 2016 | - | $1.12 M(+13.4%) |
| Mar 2016 | - | $990.60 K(-0.5%) |
| Dec 2015 | $995.10 K(+8.7%) | $995.10 K(-4.3%) |
| Sep 2015 | - | $1.04 M(+22.3%) |
| Jun 2015 | - | $850.10 K(-6.3%) |
| Mar 2015 | - | $907.10 K(-0.9%) |
| Dec 2014 | $915.10 K(-8.0%) | $915.10 K(-9.2%) |
| Sep 2014 | - | $1.01 M(+11.0%) |
| Jun 2014 | - | $908.10 K(-9.9%) |
| Mar 2014 | - | $1.01 M(+1.3%) |
| Dec 2013 | $994.40 K(-7.0%) | $994.40 K(+3.2%) |
| Sep 2013 | - | $963.80 K(-5.5%) |
| Jun 2013 | - | $1.02 M(-9.7%) |
| Mar 2013 | - | $1.13 M(+5.6%) |
| Dec 2012 | $1.07 M | $1.07 M(-14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $1.25 M(-3.8%) |
| Jun 2012 | - | $1.30 M(-4.1%) |
| Mar 2012 | - | $1.35 M(-0.9%) |
| Dec 2011 | $1.37 M(+158.2%) | $1.37 M(+29.8%) |
| Sep 2011 | - | $1.05 M(+10.2%) |
| Jun 2011 | - | $955.40 K(+9.9%) |
| Mar 2011 | - | $869.40 K(+64.3%) |
| Dec 2010 | $529.00 K(+464.6%) | $529.00 K(+0.4%) |
| Sep 2010 | - | $526.80 K(+708.0%) |
| Jun 2010 | - | $65.20 K(-0.2%) |
| Mar 2010 | - | $65.30 K(-30.3%) |
| Dec 2009 | $93.70 K(+30.0%) | $93.70 K(+135.4%) |
| Sep 2009 | - | $39.80 K(-38.5%) |
| Jun 2009 | - | $64.70 K(-25.0%) |
| Mar 2009 | - | $86.30 K(+19.7%) |
| Dec 2008 | $72.10 K(-69.3%) | $72.10 K(-3.1%) |
| Sep 2008 | - | $74.40 K(+29.2%) |
| Jun 2008 | - | $57.60 K(-51.4%) |
| Mar 2008 | - | $118.40 K(-49.6%) |
| Dec 2007 | $235.10 K(+17.3%) | $235.10 K(+43.0%) |
| Sep 2007 | - | $164.40 K(+3.2%) |
| Jun 2007 | - | $159.30 K(-17.5%) |
| Mar 2007 | - | $193.00 K(-3.7%) |
| Dec 2006 | $200.40 K(+7.5%) | $200.40 K(+3.8%) |
| Sep 2006 | - | $193.00 K(-3.2%) |
| Jun 2006 | - | $199.40 K(-25.0%) |
| Mar 2006 | - | $265.70 K(+42.5%) |
| Dec 2005 | $186.50 K(-57.8%) | $186.50 K(-4.0%) |
| Sep 2005 | - | $194.30 K(-5.3%) |
| Jun 2005 | - | $205.20 K(-23.5%) |
| Mar 2005 | - | $268.30 K(-39.3%) |
| Dec 2004 | $441.90 K(+48.9%) | $441.90 K(-11.1%) |
| Sep 2004 | - | $496.80 K(+0.9%) |
| Jun 2004 | - | $492.30 K(+54.6%) |
| Mar 2004 | - | $318.50 K(+7.3%) |
| Dec 2003 | $296.70 K(+1.1%) | $296.70 K(+0.6%) |
| Sep 2003 | - | $294.90 K(+2.4%) |
| Jun 2003 | - | $287.90 K(-1.1%) |
| Mar 2003 | - | $291.10 K(-0.8%) |
| Dec 2002 | $293.50 K(-32.9%) | $293.50 K(-10.2%) |
| Sep 2002 | - | $326.90 K(-15.4%) |
| Jun 2002 | - | $386.50 K(-7.3%) |
| Mar 2002 | - | $417.10 K(-4.7%) |
| Dec 2001 | $437.50 K(-5.6%) | $437.50 K(+3.8%) |
| Sep 2001 | - | $421.50 K(-5.4%) |
| Jun 2001 | - | $445.50 K(-10.1%) |
| Mar 2001 | - | $495.60 K(+7.0%) |
| Dec 2000 | $463.30 K | $463.30 K(+7.2%) |
| Sep 2000 | - | $432.10 K |
FAQ
- What is Cyclo Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual total liabilities year-on-year change?
- What is Cyclo Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly total liabilities year-on-year change?
What is Cyclo Therapeutics annual total liabilities?
The current annual total liabilities of CYTH is $8.49 M
What is the all time high annual total liabilities for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual total liabilities is $8.49 M
What is Cyclo Therapeutics annual total liabilities year-on-year change?
Over the past year, CYTH annual total liabilities has changed by +$5.01 M (+143.93%)
What is Cyclo Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CYTH is $18.73 M
What is the all time high quarterly total liabilities for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly total liabilities is $18.73 M
What is Cyclo Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CYTH quarterly total liabilities has changed by +$10.24 M (+120.57%)